Wednesday, 18 July 2018

Qiagen to expand biomarker research in UK

12 July 2018 | News

The new health innovation campus will support the continued growth of businesses which are driving the future shape of medicine and health care.

Image credit- hapchikov.ru

Image credit- hapchikov.ru

Qiagen has announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics.

Qiagen is working with Health Innovation Manchester, the partnership which brings together the region’s entire spectrum of public, academic and clinical resources to develop a world-leading genomics campus in the heart of Manchester’s health innovation district, anchored by Qiagen’s European Centre of Excellence for Precision Medicine and hub for diagnostics development.

The new health innovation campus, with QIAGEN at its heart, will support the continued growth of businesses which are driving the future shape of medicine and health care.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Has Health Care in Asia outpaced inflation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls